| Quarter | Prior | Estimate | Actual | Surprise | |
|---|---|---|---|---|---|
| Q4 2021 Pre-Market | EPS: REV: | 1.46 809.656M | |||
| Q3 2021 Pre-Market | EPS: REV: | 1.38 767.17M | |||
| Q2 2021 Pre-Market | EPS: REV: | ||||
| Q1 2021 Pre-Market | EPS: REV: | 1.73 860.945M | |||
| Q4 2020 Pre-Market | EPS: REV: | 1.71 809.823M | 1.33 781.34M | 1.46 809.656M | 9.77% 3.62% |
| Q3 2020 Pre-Market | EPS: REV: | 1.52 732.901M | 1.24 758.69M | 1.38 767.17M | 11.29% 1.12% |
| Q2 2020 Pre-Market | EPS: REV: | 1.21 748.697M | 1.23 768.82M | 1.53 798.929M | 24.39% 3.92% |
| Q1 2020 Pre-Market | EPS: REV: | 1.27 719.143M | 1.17 733.57M | 1.73 860.945M | 47.86% 17.36% |
| Q4 2019 After-Hours | EPS: REV: | 1.67 801.87M | 1.68 802.03M | 1.71 809.823M | 1.79% 0.97% |
| Q3 2019 Pre-Market | EPS: REV: | 1.4 732.476M | 1.25 715.31M | 1.52 732.901M | 21.6% 2.46% |
Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!
News Coverage
- Wedbush Raises Target As It Predicts Cloud Services Will Lift Microsoft Above Wall Street Estimates
- The Week Ahead In Biotech (Jan 24-30): J&J, Lilly to Kickstart Big Pharma Earnings, Amgen FDA Decision and More
- After IBM's Mixed Q4, 3 Analysts On Whether 2021 Will Be A Turnaround Year
- Union Pacific's CEO Talks Railroad's 2021 Goals
- 8 Intel Analysts On Q4 Report: Why Some See Difficult Years Ahead For Chipmaker
- Mid-Afternoon Market Update: Dow Falls 125 Points; Global Ship Lease Shares Plunge
- Mid-Day Market Update: IBM Drops On Downbeat Revenue; Montauk Renewables Shares Surge
- Coronavirus Challenges CSX's Fourth Quarter
- Kansas City Southern's Q4 Net Income Rises 30%
- Why IBM And Intel Are Trading Lower Today
